IMCR
Immunocore Holdings Ltd
30.30$
-1.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 389.5% | 248.4% | 274.1% | 3.7% | 0.4% | 2.2% | 2.1% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -289.5% | -148.4% | 100.0% | 96.3% | 99.6% | 97.8% | 97.9% | |
| 191.3% | 193.1% | 279.5% | 423.3% | 353.3% | 389.5% | 248.4% | 274.8% | 58.5% | 65.6% | 71.6% | 68.7% | |
| 38.8% | 26.1% | 22.8% | 152.5% | 144.4% | 172.1% | 151.9% | 441.1% | 65.0% | 78.5% | 62.8% | 55.6% | |
| 214.6% | 219.2% | 297.3% | 573.7% | 497.7% | 171.4% | 137.8% | 578.5% | 126.0% | 123.5% | 120.5% | 109.2% | |
| -114.6% | -119.2% | -197.3% | -467.4% | -395.1% | -460.9% | -286.2% | -478.5% | -29.7% | -23.9% | -22.7% | -11.3% | |
| – | – | 0.0% | 0.0% | 3.6% | 14.8% | 10.3% | 20.6% | 3.8% | 2.1% | 7.6% | 4.1% | |
| -112.7% | 125.8% | -189.6% | -448.1% | -372.8% | -318.2% | -290.1% | -493.0% | -23.4% | -24.4% | -17.1% | -4.8% | |
| 25.0% | 8.4% | 49.1% | 109.5% | -70.0% | 86.7% | -44.1% | 0.4% | 6.7% | -2.2% | -0.6% | 4.1% | |
| -87.7% | 117.4% | -140.5% | -343.1% | -302.8% | -404.9% | -246.0% | -493.4% | -30.1% | -22.2% | -16.5% | -8.9% | |
| -103.4% | -97.4% | -180.9% | -446.3% | -366.7% | -434.6% | -273.6% | -457.0% | -26.6% | -20.7% | -15.5% | 0.1% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.